# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: William Shakespeare (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE005-SYN-TD
- Date: 1616-02-23
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rowena Achterberg-Sule, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-week review of propranolol for essential tremor. **S**

## History of present illness

Mr. Shakespeare returns four weeks after starting propranolol extended-release 60 mg each morning. His hand is steadier: he can write a page before the script tires, though long drafts still ache and the signature at the foot of a page is the hardest part. He has had no dizziness, wheeze, cold hands, nightmares, low mood, or tiredness beyond the cold three weeks ago, which cleared without antibiotics or decongestants. He drinks about 10 standard drinks a week, no more than three on any day, and two cups of coffee. The occupational therapist's first appointment has not yet happened. He uses a heavier pen he bought himself. **S**

| Element | Detail |
|---|---|
| Medication | Propranolol extended-release 60 mg for four weeks; no side effects |
| Writing | A page before tiring; signatures still hardest |
| Alcohol | About 10 drinks a week; no day above three |
| Occupational therapy | Not yet seen; on the waiting list |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Tremor better; no new symptoms |
| Cardiovascular | Negative | No dizziness or fainting |
| Respiratory | Negative | No wheeze or breathlessness |
| Psychiatric | Negative | Mood good; sleeping well; no vivid dreams |

4 systems reviewed. **S**

## Current medications

- Propranolol extended-release 80 mg oral capsule, one capsule by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/76 mmHg; pulse 64 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 98% on room air; weight 81.6 kg; BMI 26.6 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| Cardiovascular | Heart rate 64, regular; blood pressure 122/76 mmHg seated and 120/76 mmHg standing |
| Respiratory | Clear; no wheeze |
| Neurological | Mild to moderate postural and kinetic tremor of both hands, right more than left, smaller than at diagnosis; no rest tremor or other signs |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Essential tremor** (G25.0). Partial response to propranolol 60 mg: TETRAS performance 17 (from 22), activities of daily living 14 (from 18), writing item 2. Pulse 64 and blood pressure 122/76 mmHg without symptoms leave room to increase. **S**
   - Increase propranolol extended-release to 80 mg each morning.
   - Review in four weeks; primidone remains the alternative if a higher dose is not tolerated.
2. **Hazardous drinking** (Z72.89). About 10 drinks a week with no day above three, within the agreed limits. **S**
   - Continue; GGT and liver tests at the next visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Tremor rating: TETRAS performance and activities of daily living subscales | At each visit while treatment is adjusted | Completed today | Performance 17 (from 22) and activities of daily living 14 (from 18); writing item 2 |
| Examination | Archimedes spiral and handwriting sample (the same sentence each time, dated and kept in the chart) | At each visit while treatment is adjusted | Completed today | Right spiral narrower with a smaller tremor axis; handwriting smaller and more even, still uneven at the signature |
| Medication safety | Beta-blocker safety: resting pulse, seated and standing blood pressure, wheeze, fatigue, cold hands, low mood, exercise tolerance | At each visit after starting or changing the dose | Completed today | Pulse 64; blood pressure 122/76 mmHg with no postural drop; no wheeze, fatigue, cold hands, or low mood |
| Medication safety | Drugs and substances that worsen tremor | At each medication change | Completed today | No decongestants taken during the cold; caffeine two cups; alcohol within limits |
| Self-management | Drinking review after the brief intervention (drinks a week, heaviest day, use of alcohol to steady the hand) | At each visit after a brief intervention | Completed today | About 10 drinks a week, no day above three |
| Laboratory | GGT and liver tests after reducing alcohol | Eight to twelve weeks after the brief intervention | Due | Due at the next visit, about ten weeks after the brief intervention |
| Referral | Occupational therapy evaluation for writing | Within two to four weeks of referral | Deferred | Missed: the occupational therapy evaluation requested at diagnosis four weeks ago has not taken place because of a waiting list. No harm: his writing is improving on propranolol and he is managing with a heavier pen. Corrective action: the clinic secured an appointment next week with another therapist and gave him a sheet on pen grips and forearm support in the meantime |
| Medication safety | Primidone (sedation, unsteadiness, nausea) | Only if used | Not indicated | Not started; propranolol is effective and tolerated |
| Imaging | Brain MRI or dopamine transporter imaging | Only for atypical features (rest tremor, parkinsonism, asymmetry with other signs, sudden onset, ataxia) | Not indicated | No atypical features; the diagnosis is clinical |
| Referral | Deep brain stimulation or focused ultrasound thalamotomy | Only for disabling tremor despite adequate trials of two first-line drugs | Not indicated | Tremor responding to the first drug |

## Goal progress

- Classify the tremor and exclude treatable causes by the second visit. Outcome by 1616-01-26: Essential tremor diagnosed; TSH, glucose, calcium, and kidney tests normal; no parkinsonism. **S**
- Legible handwriting for a full page and a steady signature. In progress; target 1616-04-20. **S**
- No more than 14 standard drinks a week and no more than 4 on any day. In progress; target 1616-04-20. **S**
- Resting pulse above 55 without dizziness, wheeze, or fatigue on propranolol. In progress; target 1616-04-20. **S**

## Medication changes

- Stopped: Propranolol extended-release 60 mg oral capsule, one capsule by mouth each morning **S**
- Started: Propranolol extended-release 80 mg oral capsule, one capsule by mouth each morning **S**

## Guideline basis

- Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011; reaffirmed 2025) (2011), American Academy of Neurology (Neurology)
- Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018), International Parkinson and Movement Disorder Society (Movement Disorders)
- MDS evidence-based review of treatments for essential tremor (2019), International Parkinson and Movement Disorder Society (Movement Disorders)
- Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018), U.S. Preventive Services Task Force
- Helping Patients Who Drink Too Much: A Clinician's Guide (2005), National Institute on Alcohol Abuse and Alcoholism

## Follow-up

- Four-week review on propranolol 80 mg with GGT and liver tests, a tremor rating, and pulse and blood pressure. **S**
- Next scheduled visit 1616-03-23: eight-week review: tremor and writing, propranolol at 80 mg, liver tests, and drinking. **S**
